Asia Pacific Analgesics Market Size, Share & Industry Trends Analysis Report By Type (Non-opioids and Opioids), By Route of Administration (Oral, Transdermal, Intravenous, Topical, and Rectal), By Country and Growth Forecast, 2022 - 2028

The Asia Pacific Analgesics Market would witness market growth of 7.2% CAGR during the forecast period (2022-2028).

Patients in pain should receive the most effective treatment possible. Outside of current palliative care, cancer treatment, and end-of-life care, opioids are not the primary medication for chronic pain. Non-opioid treatments, such as non-opioid drugs and nonpharmacological therapy, can relieve chronic pain while also being safer. To the degree practicable, non-opioid therapy should be used in the treatment of chronic pain. Identify and treat co-occurring mental health issues. Preferentially use first-line drug options. In patients who have failed non-invasive treatments, consider interventional therapies, such as corticosteroid injections

Non-opioid pain relievers, such as ibuprofen, acetaminophen, aspirin, and steroids are available over the counter or through prescriptions, and some people find that these are sufficient. Nondrug therapy, which can be used solely or in combination with drugs, helps some patients. A physician who specializes in physical medicine, as well as rehabilitation, may be able to design an exercise program for patients that improves their functional abilities while also reducing pain.

Consumers in numerous regional countries are less concerned with analgesic side effects. Self-medication rather than consulting a skilled physician for moderate pain and fever is a habit that is prevalent in a number of nations, most notably in India. Furthermore, consumers in most urban areas in the region are seeking quick and easy ways to relieve pain due to their extremely stressed lifestyles. This, together with the increase in purchasing power, has allowed analgesic demand and sales to increase over time. China is one of the largest pharmaceutical markets in the world, and it is thriving as a result of two primary factors, including large-scale capital investment and rapid productivity growth. These two factors indicate that the country would be a lucrative investment destination as well as a significant source of domestic savings. Since the 1970s, the country has been shifting from a low-income to a more market-oriented economy. China is experiencing a spike in the regional market due to its large-scale production capability and high analgesics consumption.

The China market dominated the Asia Pacific Analgesics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $3,391 Million by 2028. The Japan market is experiencing a CAGR of 6.5% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 7.8% during (2022 - 2028).

Based on Type, the market is segmented into Non-opioids and Opioids. Based on Route of Administration, the market is segmented into Oral, Transdermal, Intravenous, Topical, and Rectal. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Analgesics Market is Projected to reach USD 42.6 Billion by 2028, at a CAGR of 6.6%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Reckitt Benckiser Group PLC, Abbott Laboratories, Johnson & Johnson, Bayer AG, Endo International PLC, GlaxoSmithKline PLC, Pfizer, Inc., Sanofi S.A., and Eli Lilly And Company.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Non-opioids
• Opioids

By Route of Administration

• Oral
• Transdermal
• Intravenous
• Topical
• Rectal

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• AbbVie, Inc.
• Reckitt Benckiser Group PLC
• Abbott Laboratories
• Johnson & Johnson
• Bayer AG
• Endo International PLC
• GlaxoSmithKline PLC
• Pfizer, Inc.
• Sanofi S.A.
• Eli Lilly And Company

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Analgesics Market, by Type
1.4.2 Asia Pacific Analgesics Market, by Route of Administration
1.4.3 Asia Pacific Analgesics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Analgesics Market

Chapter 4. Asia Pacific Analgesics Market by Type
4.1 Asia Pacific Macro processing Market by Country
4.2 Asia Pacific Micro processing Market by Country

Chapter 5. Asia Pacific Analgesics Market by Route of Administration
5.1 Asia Pacific Oral Market by Country
5.2 Asia Pacific Transdermal Market by Country
5.3 Asia Pacific Intravenous Market by Country
5.4 Asia Pacific Topical Market by Country
5.5 Asia Pacific Rectal Market by Country

Chapter 6. Asia Pacific Analgesics Market by Country
6.1 China Analgesics Market
6.1.1 China Analgesics Market by Type
6.1.2 China Analgesics Market by Route of Administration
6.2 Japan Analgesics Market
6.2.1 Japan Analgesics Market by Type
6.2.2 Japan Analgesics Market by Route of Administration
6.3 India Analgesics Market
6.3.1 India Analgesics Market by Type
6.3.2 India Analgesics Market by Route of Administration
6.4 South Korea Analgesics Market
6.4.1 South Korea Analgesics Market by Type
6.4.2 South Korea Analgesics Market by Route of Administration
6.5 Singapore Analgesics Market
6.5.1 Singapore Analgesics Market by Type
6.5.2 Singapore Analgesics Market by Route of Administration
6.6 Malaysia Analgesics Market
6.6.1 Malaysia Analgesics Market by Type
6.6.2 Malaysia Analgesics Market by Route of Administration
6.7 Rest of Asia Pacific Analgesics Market
6.7.1 Rest of Asia Pacific Analgesics Market by Type
6.7.2 Rest of Asia Pacific Analgesics Market by Route of Administration

Chapter 7. Company Profiles
7.1 AbbVie, Inc. (Allergan PLC)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Approvals and Trials:
7.2 Reckitt Benckiser Group PLC
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.3 Abbott Laboratories
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.3.5.2 Approvals and Trials:
7.4 Johnson & Johnson
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental &Regional Analysis
7.4.4 Research & Development Expenses
7.5 Bayer AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Product Launches and Product Expansions:
7.6 Endo International PLC
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 GlaxoSmithKline PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Geographical Expansions:
7.8 Pfizer, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional & Segmental Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Partnerships, Collaborations, and Agreements:
7.9 Sanofi S.A.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.10. Eli Lilly And Company
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Partnerships, Collaborations, and Agreements:
7.10.5.2 Geographical Expansions:

TABLE 1 Asia Pacific Analgesics Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Analgesics Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Macro processing Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Macro processing Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Micro processing Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Micro processing Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Transdermal Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Transdermal Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Intravenous Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Intravenous Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Topical Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Topical Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Rectal Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Rectal Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Analgesics Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Analgesics Market by Country, 2022 - 2028, USD Million
TABLE 23 China Analgesics Market, 2018 - 2021, USD Million
TABLE 24 China Analgesics Market, 2022 - 2028, USD Million
TABLE 25 China Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 26 China Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 27 China Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 28 China Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 29 Japan Analgesics Market, 2018 - 2021, USD Million
TABLE 30 Japan Analgesics Market, 2022 - 2028, USD Million
TABLE 31 Japan Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 32 Japan Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 33 Japan Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 34 Japan Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 35 India Analgesics Market, 2018 - 2021, USD Million
TABLE 36 India Analgesics Market, 2022 - 2028, USD Million
TABLE 37 India Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 38 India Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 39 India Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 40 India Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 41 South Korea Analgesics Market, 2018 - 2021, USD Million
TABLE 42 South Korea Analgesics Market, 2022 - 2028, USD Million
TABLE 43 South Korea Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 44 South Korea Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 45 South Korea Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 46 South Korea Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 47 Singapore Analgesics Market, 2018 - 2021, USD Million
TABLE 48 Singapore Analgesics Market, 2022 - 2028, USD Million
TABLE 49 Singapore Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 50 Singapore Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 51 Singapore Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 52 Singapore Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 53 Malaysia Analgesics Market, 2018 - 2021, USD Million
TABLE 54 Malaysia Analgesics Market, 2022 - 2028, USD Million
TABLE 55 Malaysia Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 56 Malaysia Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 57 Malaysia Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 58 Malaysia Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 59 Rest of Asia Pacific Analgesics Market, 2018 - 2021, USD Million
TABLE 60 Rest of Asia Pacific Analgesics Market, 2022 - 2028, USD Million
TABLE 61 Rest of Asia Pacific Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 62 Rest of Asia Pacific Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 63 Rest of Asia Pacific Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 64 Rest of Asia Pacific Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 65 Key information – AbbVie, Inc.
TABLE 66 Key information – Reckitt Benckiser Group PLC
TABLE 67 Key Information – Abbott Laboratories
TABLE 68 Key information – Johnson & Johnson
TABLE 69 Key Information – Bayer AG
TABLE 70 Key Information – Endo International PLC
TABLE 71 Key Information – GlaxoSmithKline PLC
TABLE 72 Key Information – Pfizer, Inc.
TABLE 73 Key Information – Sanofi S.A.
TABLE 74 Key Information – Eli Lilly And Company

List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Abbott Laboratories
FIG 3 Recent strategies and developments: Eli Lilly And Company